BioVendor – Laboratorni Medicina as-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:BioVendor - Laboratorni Medicina as - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011847
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:チェコ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioVendor – Laboratorni Medicina as (BioVendor) is a developer and manufacturer of immunoassays, recombinant protiens, antibodies and endotoxin-removal products. The company’s products include immunoassays, proteins, antibodies, endotoxin removal products, endotoxin detection products, immuno-histochemistry, cell-based assays and colorimetric assays. Its products are used in animal studies, apoptosis, asthma and allergic rhinitis, atherosclerosis, autoimmunity, blood pressure regulation and no metabolism, bone and cartilage metabolism, cardiovascular disease, cell adhesion proteins and other research applications. The company sells its products through a network of distributors in Andorra, Belgium, Cyprus, Denmark, Finland, France, Greece, Greenland, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, the Czech Republic and the UK, among others. BioVendor is headquartered in Brno, the Czech Republic.

BioVendor – Laboratorni Medicina as – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BioVendor – Laboratorni Medicina as, Medical Devices Deals, 2011 to YTD 2017 9
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
BioVendor – Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 11
Licensing Agreements 12
BioVendor Enters into Licensing Agreement with Atlantic Cancer Research Institute 12
Acquisition 13
Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 13
BioVendor – Laboratorni Medicina as – Key Competitors 14
BioVendor – Laboratorni Medicina as – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Key Facts 2
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioVendor - Laboratorni Medicina as, Deals By Therapy Area, 2011 to YTD 2017 8
BioVendor - Laboratorni Medicina as, Medical Devices Deals, 2011 to YTD 2017 9
BioVendor - Laboratorni Medicina as, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 11
BioVendor Enters into Licensing Agreement with Atlantic Cancer Research Institute 12
Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 13
BioVendor - Laboratorni Medicina as, Key Competitors 14
BioVendor - Laboratorni Medicina as, Subsidiaries 15

★海外企業調査レポート[BioVendor – Laboratorni Medicina as-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Strides Pharma Science Limited (STAR):医療機器:M&Aディール及び事業提携情報
    Summary Strides Pharma Science Limited (Strides Pharma), formerly Strides Shasun Ltd, is a pharmaceutical company which offers generic products. It focuses on the development and manufacture of intellectual property- led niche pharmaceutical products, over-the-counter drugs and nutraceuticals. The c …
  • Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on …
  • Chagala Group Limited:企業の戦略・SWOT・財務情報
    Chagala Group Limited - Strategy, SWOT and Corporate Finance Report Summary Chagala Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Postal Savings Bank of China Co., Ltd. (1658):企業の財務・戦略的SWOT分析
    Postal Savings Bank of China Co., Ltd. (1658) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • PNE Wind AG (PNE3):電力:M&Aディール及び事業提携情報
    Summary PNE Wind AG (PNE) is a renewable energy company, which develops onshore and offshore wind farms. It has a presence in the wind energy value chain, from site exploration and implementation of approval procedure, financing and turnkey construction to operation and repowering. The company also …
  • Duke Energy Carolinas LLC:企業の戦略的SWOT分析
    Duke Energy Carolinas LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Globo Comunicacao e Participacoes S.A.:企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Turner Broadcasting System Inc:企業の戦略的SWOT分析
    Turner Broadcasting System Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • TOKIN Corp:企業の戦略的SWOT分析
    TOKIN Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Natera Inc (NTRA)-医療機器分野:企業M&A・提携分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • GLG Life Tech Corp (GLG):企業の財務・戦略的SWOT分析
    GLG Life Tech Corp (GLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • SpectraScience Inc (SCIE):企業の財務・戦略的SWOT分析
    SpectraScience Inc (SCIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Astellas Pharma Inc (4503):医療機器:M&Aディール及び事業提携情報
    Summary Astellas Pharma Inc (Astellas) is a research based pharmaceutical company that discovers, develops, manufactures, and commercializes a wide range of pharmaceuticals. The company’s product portfolio comprises both marketed products for the treatment of a wide range of urological diseases, inf …
  • Savara Inc (SVRA):企業の財務・戦略的SWOT分析
    Savara Inc (SVRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mega Corporation Ltd
    Mega Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mega Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SciDev Ltd:企業の戦略・SWOT・財務分析
    SciDev Ltd - Strategy, SWOT and Corporate Finance Report Summary SciDev Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • The Save Mart Companies:戦略・SWOT・企業財務分析
    The Save Mart Companies - Strategy, SWOT and Corporate Finance Report Summary The Save Mart Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Marks and Spencer Group plc:企業の戦略・SWOT・財務分析
    Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report Summary Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Fluor Corp (FLR):企業の財務・戦略的SWOT分析
    Fluor Corp (FLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • UBS Wealth Management:企業の戦略・SWOT・財務情報
    UBS Wealth Management - Strategy, SWOT and Corporate Finance Report Summary UBS Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆